ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Lygos gets funding for malonic acid

by Melody M. Bomgardner
January 2, 2017 | APPEARED IN VOLUME 95, ISSUE 1

Biobased chemical start-up Lygos has raised $13 million in a first round of venture funding. Using synthetic biology methods, Lygos developed yeast strains that produce malonic acid, an intermediate used in flavors, fragrances, and pharmaceuticals that is currently made with a cyanide-based route. The company says it is producing sample quantities of bio-malonic acid. It will use the funds to scale up output to ton quantities and expand its workforce.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment